106 related articles for article (PubMed ID: 1367917)
1. Gene expression using retroviral vectors.
Tolstoshev P; Anderson WF
Curr Opin Biotechnol; 1990 Oct; 1(1):55-61. PubMed ID: 1367917
[No Abstract] [Full Text] [Related]
2. Genetic engineering of mouse and human stem cells.
Bernstein A; Dick JE; Huszar D; Robson I; Rossant J; Magli C; Estrov Z; Freedman M; Phillips RA
Cold Spring Harb Symp Quant Biol; 1986; 51 Pt 2():1083-91. PubMed ID: 3472753
[No Abstract] [Full Text] [Related]
3. Retroviral vector-mediated gene transfer and expression in nonhuman primates following autologous bone marrow transplantation.
Gillio A; Bordignon C; Kernan N; Kantoff P; Eglitis M; McLachlin J; Karson E; Yu SF; Zwiebel J; Nienhuis A
Ann N Y Acad Sci; 1987; 511():406-17. PubMed ID: 2894194
[No Abstract] [Full Text] [Related]
4. Use of a retroviral vector to study the trafficking patterns of purified ovarian tumor infiltrating lymphocytes (TIL) used in intraperitoneal adoptive immunotherapy of ovarian cancer patients. A pilot study.
Freedman RS; Platsoucas CD; Deisseroth AB
Hum Gene Ther; 1996 Jul; 7(11):1351-65. PubMed ID: 8818723
[No Abstract] [Full Text] [Related]
5. Prospects for human gene therapy in the born and unborn patient.
Anderson WF
Clin Obstet Gynecol; 1986 Sep; 29(3):586-94. PubMed ID: 3463443
[No Abstract] [Full Text] [Related]
6. Gene replacement therapy for inborn errors of purine metabolism.
Nelson DL; Chang SM; Henkel-Tigges J; Wager-Smith K; Belmont JW; Caskey CT
Cold Spring Harb Symp Quant Biol; 1986; 51 Pt 2():1065-71. PubMed ID: 3555977
[TBL] [Abstract][Full Text] [Related]
7. Retroviral-mediated gene transfer into mammalian cells.
Kohn DB; Kantoff PW; Eglitis MA; McLachlin JR; Moen RC; Karson E; Zwiebel JA; Nienhuis A; Karlsson S; O'Reilly R
Blood Cells; 1987; 13(1-2):285-98. PubMed ID: 3311223
[TBL] [Abstract][Full Text] [Related]
8. Gene transfer and expression in nonhuman primates using retroviral vectors.
Anderson WF; Kantoff P; Eglitis M; McLachlin J; Karson E; Zwiebel J; Nienhuis A; Karlsson S; Blaese RM; Kohn D
Cold Spring Harb Symp Quant Biol; 1986; 51 Pt 2():1073-81. PubMed ID: 3034494
[No Abstract] [Full Text] [Related]
9. Evaluation of lymphoid-specific enhancer addition or substitution in a basic retrovirus vector.
Moore KA; Scarpa M; Kooyer S; Utter A; Caskey CT; Belmont JW
Hum Gene Ther; 1991; 2(4):307-15. PubMed ID: 1838933
[TBL] [Abstract][Full Text] [Related]
10. Towards gene therapy for adenosine deaminase deficiency.
Belmont JW; Henkel-Tigges J; Wager-Smith K; Chang SM; Caskey CT
Ann Clin Res; 1986; 18(5-6):322-6. PubMed ID: 3471172
[No Abstract] [Full Text] [Related]
11. Gene transfer into animals by retroviral vectors.
Anderson WF; Kantoff PW; Eglitis MA; Gilboa E
Basic Life Sci; 1986; 37():59-65. PubMed ID: 3010936
[No Abstract] [Full Text] [Related]
12. Expression vectors for human adenosine deaminase gene therapy.
Moore KA; Fletcher FA; Alford RL; Villalon DK; Hawkins DH; MacGregor GR; Caskey CT; Belmont JW
Genome; 1989; 31(2):832-9. PubMed ID: 2576653
[TBL] [Abstract][Full Text] [Related]
13. Long-term expression of human adenosine deaminase in mice after transplantation of bone marrow infected with amphotropic retroviral vectors.
Osborne WR; Hock RA; Kaleko M; Miller AD
Hum Gene Ther; 1990; 1(1):31-41. PubMed ID: 2081183
[TBL] [Abstract][Full Text] [Related]
14. The use of gene-modified tumor-infiltrating lymphocytes for cancer therapy.
Hwu P; Rosenberg SA
Ann N Y Acad Sci; 1994 May; 716():188-97; discussion 197-203. PubMed ID: 8024194
[No Abstract] [Full Text] [Related]
15. Murine retroviral vectors and human gene therapy.
Cooper DN
Science; 1985 May; 228(4700):650, 653. PubMed ID: 3857706
[No Abstract] [Full Text] [Related]
16. Molecular analysis of T lymphocyte-directed gene therapy for adenosine deaminase deficiency: long-term expression in vivo of genes introduced with a retroviral vector.
Mullen CA; Snitzer K; Culver KW; Morgan RA; Anderson WF; Blaese RM
Hum Gene Ther; 1996 Jun; 7(9):1123-9. PubMed ID: 8773514
[TBL] [Abstract][Full Text] [Related]
17. Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells.
Rivière I; Brose K; Mulligan RC
Proc Natl Acad Sci U S A; 1995 Jul; 92(15):6733-7. PubMed ID: 7624312
[TBL] [Abstract][Full Text] [Related]
18. In vivo expression and survival of gene-modified T lymphocytes in rhesus monkeys.
Culver KW; Morgan RA; Osborne WR; Lee RT; Lenschow D; Able C; Cornetta K; Anderson WF; Blaese RM
Hum Gene Ther; 1990; 1(4):399-410. PubMed ID: 1964096
[TBL] [Abstract][Full Text] [Related]
19. Genetic manipulation of hematopoietic stem cells in adenosine deaminase deficiency.
Williams DA; Moritz T
Adv Exp Med Biol; 1994; 370():395-400. PubMed ID: 7660937
[No Abstract] [Full Text] [Related]
20. Long-term expression of retroviral-transduced adenosine deaminase in human primitive hematopoietic progenitors.
Mitani K; Wakamiya M; Caskey CT
Hum Gene Ther; 1993 Feb; 4(1):9-16. PubMed ID: 8461384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
